Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Porter

Showing results (331-340 of 764) with videos related to

Pageof 77
Sort By:
Child: Care, Health and Development|November 19, 2010
Management of problems related to the new morbidity by community-based paediatricians in IsraelK Oren, I Shoham-Vardi, B Reichman, et al.
Journal of Veterinary Internal Medicine|July 24, 2008
Epidemiology of necrotizing meningoencephalitis in Pug dogsJ M Levine, G T Fosgate, B Porter, et al.
Obstetrics and Gynecology|March 1, 1982
Oral contraceptives and nonfatal vascular disease--recent experienceJ B Porter, J R Hunter, D A Danielson, et al.
Developmental Medicine and Child Neurology|December 1, 1991
Weissenbacher-Zweymuller syndrome: long-term follow-up of growth and psychomotor developmentA Galil, R Carmi, E Goldstein, et al.
British Journal of Haematology|December 31, 1997
Non-transferrin-bound iron induced by myeloablative chemotherapyS J Bradley, I Gosriwitana, S Srichairatanakool, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 6, 2004
Mikanolide from Jamaican Mikania micranthaMohammed Bakir, Petrea C Facey, Ishmael Hassan, et al.
Blood|July 15, 1996
Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapyJ B Porter, R D Abeysinghe, L Marshall, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 24, 2021
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla<sub>CTX-M</sub> genotype, and resistance to comparator agentsBrian D Johnston, Paul Thuras, Stephen B Porter, et al.
Journal of Vascular Surgery|March 10, 2000
Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot studyS S Shoab, J B Porter, J H Scurr, et al.
Harefuah|January 1, 1978
[Delayed hemopericardium after penetrating injury]A Gedalia, B Porter, M Gueron, et al.
Pageof 77

Showing results (331-340 of 764) with videos related to

Sort By:
Pageof 77
Child: Care, Health and Development|November 19, 2010
Management of problems related to the new morbidity by community-based paediatricians in IsraelK Oren, I Shoham-Vardi, B Reichman, et al.
Journal of Veterinary Internal Medicine|July 24, 2008
Epidemiology of necrotizing meningoencephalitis in Pug dogsJ M Levine, G T Fosgate, B Porter, et al.
Obstetrics and Gynecology|March 1, 1982
Oral contraceptives and nonfatal vascular disease--recent experienceJ B Porter, J R Hunter, D A Danielson, et al.
Developmental Medicine and Child Neurology|December 1, 1991
Weissenbacher-Zweymuller syndrome: long-term follow-up of growth and psychomotor developmentA Galil, R Carmi, E Goldstein, et al.
British Journal of Haematology|December 31, 1997
Non-transferrin-bound iron induced by myeloablative chemotherapyS J Bradley, I Gosriwitana, S Srichairatanakool, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 6, 2004
Mikanolide from Jamaican Mikania micranthaMohammed Bakir, Petrea C Facey, Ishmael Hassan, et al.
Blood|July 15, 1996
Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapyJ B Porter, R D Abeysinghe, L Marshall, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 24, 2021
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla<sub>CTX-M</sub> genotype, and resistance to comparator agentsBrian D Johnston, Paul Thuras, Stephen B Porter, et al.
Journal of Vascular Surgery|March 10, 2000
Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot studyS S Shoab, J B Porter, J H Scurr, et al.
Harefuah|January 1, 1978
[Delayed hemopericardium after penetrating injury]A Gedalia, B Porter, M Gueron, et al.
Pageof 77